D-Leucine benzyl ester tosylate

D-Leucine benzyl ester tosylate is a D-configured leucine derivative in which the amino acid carboxyl group is present as a benzyl ester and the amino functionality is converted to a tosylate (tosyl-protected amine). The molecule therefore contains a stereogenic center at the leucine backbone, a hydrophobic isobutyl side chain characteristic of leucine, and an aromatic benzyl ester moiety that can be removed under hydrogenolysis-type conditions while the tosyl group provides robust amine masking during peptide coupling steps. The tosylate also introduces a strongly electron-withdrawing sulfonyl substituent that modulates nucleophilicity at nitrogen, supporting controlled deprotection and selective functional group interconversions. As a chiral amino acid ester sulfonate, D-Leucine benzyl ester tosylate functions as a process-compatible intermediate for protected amino acid synthesis, enabling downstream conversion into coupling-ready D-leucine derivatives and stereochemically defined peptide building blocks.

1. Protected Amino Acid Synthesis

D-Leucine benzyl ester tosylate supports protected amino acid synthesis workflows where orthogonal protection is required for sequential transformations. The benzyl ester provides a protected carboxyl handle that can be carried through amine-directed chemistry, while the tosyl-protected nitrogen suppresses premature side reactions such as uncontrolled amide formation or side-chain nucleophilicity. The D stereochemistry at the leucine center enables stereodefined incorporation into peptide coupling sequences, including routes that prepare coupling reagents or activated esters for fragment assembly. Downstream processing can convert the protected amino acid into other N-protected D-leucine derivatives, supporting consistent stereochemical outcomes in fine chemical synthesis and research intermediate preparation.

2. Peptide Coupling Chemistry

D-Leucine benzyl ester tosylate can be applied in peptide coupling chemistry as a chiral, protection-controlled precursor that aligns with standard amino acid ester and sulfonamide protection strategies. The tosyl-protected amine serves as a stable nitrogen protecting group during manipulations of the ester carbonyl, while the benzyl ester can be transformed into carboxyl-activated species or deprotected to yield a coupling-ready acid derivative. The leucine side chain contributes hydrophobic character that often improves solubility management and can influence peptide conformational preferences during synthesis planning. Stereochemically defined D-leucine incorporation can be used to construct D-amino acid-containing peptides and peptidomimetic scaffolds for structure-activity relationship studies and method development in peptide science.

3. Chiral Building Block Production

D-Leucine benzyl ester tosylate is suitable for chiral building block production where maintaining D-configuration is central to product identity and downstream stereochemical integrity. The compound's protected functional groups, namely the benzyl ester and tosylate, provide a controlled reactivity profile that can be leveraged in multistep synthesis of chiral amino acid intermediates without exposing an unprotected amine or carboxylic acid. The sulfonamide-like tosyl protection enables selective deprotection strategies that regenerate an amine for further derivatization, while the benzyl ester supports orthogonal handling of the carboxyl functionality. Industrially relevant routes may use such intermediates to manufacture stereodefined amino acid derivatives for peptide manufacturing, specialty chemical production, and process chemistry intermediate preparation.

4. Peptidomimetic And SAR Studies

D-Leucine benzyl ester tosylate can be used in peptidomimetic construction for chemical biology and SAR studies where D-amino acid incorporation modulates peptide stability and backbone recognition. The leucine isobutyl side chain provides a hydrophobic residue commonly used to tune binding pocket interactions, while the protected amine and ester enable controlled assembly into peptide analogs or hybrid scaffolds. Orthogonal protection strategies allow sequential functional group transformations, supporting synthesis of analog libraries with defined stereochemistry at the D-leucine center. Downstream derivatives derived from this intermediate can serve as standardized building blocks for comparative SAR investigations and analytical reference materials in amino acid and peptide research.

5. Pharmaceutical Intermediate Preparation

D-Leucine benzyl ester tosylate is applicable to pharmaceutical intermediate preparation where controlled protection and stereochemical definition are required for downstream synthesis of D-amino acid-containing intermediates. The tosylate masking of the amine supports safe handling during steps that modify or activate the carboxyl functionality, while the benzyl ester provides a removable protecting group strategy aligned with manufacturing-grade orthogonality concepts. The compound's chiral amino acid framework can be converted into other protected D-leucine derivatives used as inputs for peptide-like building blocks, fragment couplings, or stereodefined scaffold elaboration. The resulting downstream intermediates can feed fine chemical synthesis and pharmaceutical manufacturing workflows that rely on reproducible amino acid chemistry and predictable functional group behavior.

1. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

2. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

3. The spatiotemporal control of signalling and trafficking of the GLP-1R

4. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

5. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors